Showing results (431-440 of 2,146) with videos related to
Sort By:
Pageof 215
Clinical Therapeutics|January 1, 1990
Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis BJ Hayashi, A Noguchi, K Nakashima, et al.The Journal of Infection|May 1, 1997
Usefulness of HCV-RNA assays in efficacy evaluation of interferon treatment for chronic hepatitis C: Amplicor HCV assay and branched DNA probe assayH Nomura, Y Kimura, N Rikimaru, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 1, 1993
[Immunogenicity of Chinese hamster ovary cell derived HB vaccine--a comparative study with yeast derived HB vaccine]S Kashiwagi, J Hayashi, K Nakashima, et al.Clinical Therapeutics|January 28, 1998
Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosisN Furusyo, J Hayashi, K Ueno, et al.Fukuoka Igaku Zasshi = Hukuoka Acta Medica|February 18, 1998
Large dose natural interferon alpha therapy for patients with chronic hepatitis CM Ohmiya, J Hayashi, N Furusyo, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 1, 1990
[An epidemiological study of HBV and HTLV-I among high risk groups in Fukuoka City]K Nakashima, S Kashiwagi, A Noguchi, et al.Japanese Journal of Medicine|May 1, 1988
Electrocardiographic changes related to hypersecretion of catecholamine in a patient with fulminant hepatitisJ Hayashi, S Kashiwagi, T Okeda, et al.Gastroenterologia Japonica|February 1, 1990
Prevalence of IgM anti-HBc among HBsAg carriers in Okinawa, JapanJ Hayashi, S Kashiwagi, A Noguchi, et al.Clinical and Experimental Immunology|September 1, 1985
Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitisS Nagafuchi, S Kashiwagi, S Hayashi, et al.Biochemistry|February 24, 2000
Metabolism of 1alpha,25-dihydroxyvitamin D(3) in vitamin D receptor-ablated mice in vivoB Endres, S Kato, H F DeLucaPageof 215